Abstract
The World Health Organization classification divides thymomas according to morphology, epithelial component, and cell atypia. They are grouped into 3 large subgroups: low-risk thymomas (types A, AB, and B1), high-risk thymomas (types B2 and B3), and thymic carcinomas. Tumor subtype represents an independent prognostic factor, which determines therapeutic decision. All thymomas show some degree of 18F-FDG uptake, which tends to increase with the grade of malignancy; this is related to glucose transporter 1 (GLUT1) expression. This review collects all types of thymomas with illustrative images and provides a guide to get familiar with histological characteristics of the lesions and have them in mind because, even imaging findings can overlap among subtypes, certain characteristics can be combined to make an accurate diagnosis based on 18F-FDG PET-CT findings.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13139-021-00705-7/MediaObjects/13139_2021_705_Fig7_HTML.png)
Data Availability
N/A
Code Availability
N/A
References
Rouse RV (2017/09/07) Stanford Medicine Surgical Pathology Criteria. Retrieved from: http://surgpathcriteria.stanford.edu/thymus/thymoma/. Accessed 20 Jan 2021
Sharma P, Singhal A, Kumar A, Bal C, Malhotra A, Kumar R. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review. Acta Radiol. 2013;54:14–21.
Endoa M, Nakagawab K, Ohdeb Y, Okumurab T, Kondob H, Igawac S, et al. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer. 2008;61:350–5.
Sasaki M, Kuwabara Y, Ichiya Y, et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med. 1999;40:1595–601.
Sung YM, Lee KS, Kim B-T, Choi JY, Shim YM, Yi CA. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med. 2006;47:1628–34.
Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, et al. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer. 2008;61:350–5.
Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T. Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors. Cancer Manag Res. 2017;9:761–8.
Benveniste MF, Moran CA, Mawlawi O, et al. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol. 2013;8(4):502–10.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and case review were performed by Vanessa Murad. The first draft of the manuscript was written by Vanessa Murad and E. Edmund Kim commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Ethical approval was waived by the institutional ethics committee in view of the retrospective nature of the study.
Consent to Participate
N/A
Consent for Publication
N/A
Competing Interests
Vanessa Murad and E. Edmund Kim declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Murad, V., Kim, E.E. 18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review. Nucl Med Mol Imaging 55, 186–193 (2021). https://doi.org/10.1007/s13139-021-00705-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-021-00705-7